- Published at
- by investing.com
mixed
mixed
IBRX stock touches 52-week low at $3.12 amid market challenges By Investing.com
IBRX stock touches 52-week low at $3.12 amid market challenges
News for Nantkwest Inc (NK)
- Published at
- by seekingalpha.com
mixedmixedImmunityBio: Anktiva Approval Opens Possibilities, Risks And Potential Gains (NASDAQ:IBRX)
ImmunityBio's founder, Dr. Patrick Soon-Shiong, owns a majority and plans to launch five new drugs between 2021 and 2025. See why IBRX stock is rated a buy.- Published at
- by globenewswire.com
negativenegativeNatural Killer (NK) Cell Therapeutics Market: Pioneering Immunotherapy for Cancer Treatment with market Size & Share to Exceed USD 114119.6 Million by 2034, at CAGR of 41.70% – By PMI
“Natural Killer (NK) Cell Therapeutics Market” from 2024-2034 with covered segments (Natural Killer (NK) Cell Therapeutics Market, By Type (NK Cell...- Published at
- by prnewswire.com
mixedmixedNatural Killer Cells Therapeutics Market Analysis and Industry Forecast Report 2023: Focus on Cancer Immunotherapy, Infectious Diseases and Autoimmune Disorders
/PRNewswire/ -- The "Natural Killer Cells Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2027" report has been added to...- Published at
- by prnewswire.com
mixedmixedGlobal Engineered T Cells Market Report 2022-2027: Immuno-Oncology Sector Increasing R&D Funding & Expanding Gene Therapy Marketspace Generating High-Potential Opportunities
/PRNewswire/ --The "Global Engineered T Cells Market (2022-2027) by Type, Application, End User, Geography, Competitive Analysis and the Impact of Covid-19...- Published at
- by globenewswire.com
mixedmixedHarpoon Therapeutics Expands Leadership Team
Appointments named for two key executive leadership positions in human resources and translational medicine SOUTH SAN FRANCISCO, Calif., July 06, 2022 ...- Published at
- by etfdailynews.com
positivepositiveImmunityBio (NASDAQ:IBRX) Downgraded to “Sell” at Zacks Investment Research
Read ImmunityBio (NASDAQ:IBRX) Downgraded to “Sell” at Zacks Investment Research at ETF Daily News- Published at
- by etfdailynews.com
positivepositive- Published at
- by etfdailynews.com
mixedmixedResearch Analysts’ Downgrades for May 3rd (ADDYY, AI, AMGN, AO, AOWDF, CHGG, CHTR, CL, CVNA, DOCU)
Read Research Analysts’ Downgrades for May 3rd (ADDYY, AI, AMGN, AO, AOWDF, CHGG, CHTR, CL, CVNA, DOCU) at ETF Daily NewsWATTVVNTVBIVUNITTSNTRHCTREX1.MXTREXTNETTMPTHGTELLSSKNSRTSSPFR-UNSPFRSNPSSAILRGNXPUKPFPUK-WIPUK-PPUKPRU.LPRU.DEPPSIPLYM-PAPLYMOVIDOPCHOKTA.MXOKTAOCULO1KT34.SANYCBNTUSNOA.TONOANHIMTRO.LMPMOLN.SWMLLCFMBNKFLOBLMATINVAIMUXEDDOCUCMTVCCXAFINPAFINOAFINAEPTDAEPTADSN.MXADS.MIADS.DEADDYYADDDF2378.HK0QXX.L0LJB.L0LE3.L0KB7.L0IH3.LVYNTUGRODUGROTKPHFTAKP34.SATAKN.MXTAKTASNCASLDBSFTSEKEYSEKEFPSOPRAXPALIOPYNKMTTRLXFRKJPMMLJPMJELDIPHAICDHZON-WTHZAC-WTHZAC-UNHZACHEIGSBDGGGFVT-WTFVIVFVACFAII-WTEVERCVNACSN.MXCSGNE.SWCSGN.SWCSGKFCSCLCHTRCF.TOCCORFAOWDFAMGNAI6724.T4502.T4502.S0I4P.L0A87.LWFCIPHYFIPH.PAIBRXCHGGCGIX- Published at
- by etfdailynews.com
mixedmixedImmunityBio (NASDAQ:IBRX) Rating Lowered to Sell at Zacks Investment Research
Read ImmunityBio (NASDAQ:IBRX) Rating Lowered to Sell at Zacks Investment Research at ETF Daily News- Published at
- by benzinga.com
positivepositive- Published at
- by rttnews.com
mixedmixedBLUE To Face FDA Next Month, SNSS Catches Eyes, ADVM On Watch
Today's Daily Dose brings you news about the earnings date of Adverum, near-term catalyst of bluebird bio, Predictive Oncology's private placement of common stock, and analyst rating of Sunesis Pharma.- Published at
- by benzinga.com
mixedmixedThe Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 22) ...XNCRXE9.SGXE9.MUXE9.FXE9.BEPLX.TAPLXPENPBDA.MUPBDA.FPBDA.BEPAVMMGNXMDTN.MXMDTM55.FM55.BEJAZZN.MXJAZZJ7Z.SGJ7Z.MUJ7Z.FJ7Z.BEHALOFREQARDS2M6.MU2M6.F2M6.DE2M6.BE1P5.SG1P5.F0P8.MU0P8.FXLRNVTGNVLONVCNXUS972G108.FUS972G108.BETLISTCE2.MUTCE2.FTCE2.BETBPHSURFSLNRVNCRV7.MURV7.FRV7.BERUBYRTI.FRN3N.MURN3N.FRDHLQSOA.MUQSOA.FQSOA.BEPODDPLRXPHVSPHARMYGNMYD.SGMYD.MUMYD.FMYD.DEMYD.BEMASI.MXMASIINSPICCCGOV.MUGOV.FGOV.BEGMTXESPREPZMEPE.FEPE.BEDMTK.MXDMTKCTXRCLVSCLDXCERCCELCC6O.MUC6O.FC6O.DEC6O.BEC6K.FBNRBLUE.MXBLUEBLE.MUBLE.FATRCARNAANNXAMTIAKTXADMSA5I.F9PT.MU9PT.F5RT.SG5RT.MU5RT.F5RT.BE47N.F3M4.MU3M4.F3M4.BE2RH.MU2RH.F2RH.BE2DR.MU2DR.F2DR.BE23I.MU23I.F23I.BE136.F0ET.F0A3.FUTHRUTH.SGUTH.MUUTH.FUTH.BEONYN.FONYN.BEONCYONCWFONC.TOOM2.FOFIXNKMPH.LITOSITCI- Published at
- by marketscreener.com
neutralneutralSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Merger Investigation
WILMINGTON, Del., Feb. 20, 2021 -- Rigrodsky Law, P.A. announces that it is investigating: NantKwest, Inc. regarding possible breaches of fiduciary duties and other violations of law...- Published at
- by benzinga.com
neutralneutralSHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Merger Investigation
WILMINGTON, Del., Feb. 20, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating: NantKwest, Inc. (NASDAQ GS: NK) regarding ...- Published at
- by benzinga.com
mixedmixedStocks That Hit 52-Week Highs On Friday
Friday morning saw 331 companies set new 52-week highs. Things to Consider: The largest company by market cap to break to a new 52-week high ...ZNGAZIXIWORWLLWKWIXWHWDCWBTWBKWATTVTGNVMIVERXVECOUTZUHALTYLTWTRTWNDTRSTRQTRNSTPCTMQ.TOTMQTMDXTLMDTIGRTHRMTFCTDACTCOMTCBITBKTACSXISSTKSNAPSLQTSLABSIXSIVBSFNCSFBSSEASSCPLRYC.SGRY.TORYROGRMBSRJFRION.MXRHIREZIRAVNQTRXPTCPSECPRFXPATKPARPANWPANDOSSONTOOLWN.FOLNNTAPNNM.FNKNDAQNARIMVBFMU.MIMUMTNMS.MXMSMPMNROMMYTMMIMLSSMLMMGAMFINMETCMCYMBINLYFTLTRXLSTRLPXLPLLNNLATNULATNLASRKSSKRYSKRUSKRNTKRAKIDSKFY.FKFY.BEKFYKALUITCIINSEWINSEIINIHGIBKRIBEXHUBSHMSTHLXAHLNEGSGCOFVAMFTNTFRTAFOCSFIVNFITBFFH.BEFEIMFCXFBPFBKEXFOEVBGEOLSENVAEATDXYNDWD.SGDWD.MUDWD.FDWD.BEDMTKDELLCVNACTVACTRNCTBCSWICROXCOUPCOLBCNNBCMBMCETCDXCCBRECATCASACAMTCAIBSACBSA.SGBSA.MUBSA.FBOMNBNS.TOBNSBLSABKN.FBCOVBANFAXU.FAXTIAVGOASANARCANNXANFANETAMPAMBAAMATALGAGYSAGCOADIACTGABRABCBZBRA.MXZBRAXNETVEDLVCNXUMBFTDB.SGTDB.MUTDB.FTDB.BETD.TOTDSUMRENNPBTNCTYMYGNMKGIMCHXMATLEVIKWRKFRCJPMHBMGSHDGPREFTCHFAROCTXRCNHICFXBLMNAPGAEGTWTEAMTCSTCBKROLLQFINLYVHGVEXPEEXPEGOVDRICLIRCLGXCLDXCANBHPBBL3E0.F- Published at
- by benzinga.com
mixedmixedThe Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 19) ...XCY.SGXCY.MUXCY.FXCY.BEQDELOPK.TAOPK.MXOPKDTILTCE2.MUTCE2.FTCE2.BERI2A.MURI2A.FRI2A.BEPRTAPFED.BAPFE.SGPFE.MXPFE.MUPFE.FPFE.DEPFE.BEPFENVV1.MUNVV1.FNVV1.BENVAX.MXNVAXNKMPH.LMJC.MUMJC.FEO7.MUEO7.FEO7.BEENDPCBMGBNTXN.MXBNTXAVNSANGNAMTI8HH.MU8HH.F8HH.BE7CB1.F7CB1.BE22UA.MU22UA.F22UA.DE22UA.BE0T22.SG0T22.MU0T22.F0T22.BE0PT.FUQ1.FUQ1.BESANARIGLRDYRDDA.MURDDA.FRDDA.BEQURELLY.SGLLY.FLLY.DELLY.BALLYDRREDDY.NSALBPS.PA6XB.F- Published at
- by benzinga.com
mixedmixedThe Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16) 10X ...YMABUS87166B1026.SGTLISSYNHSNCASESNSEELPTGXPRTAPPDPCBK.MUPCBK.FPCBK.BEPAVMORMPNXEN.SGNXEN.FNXEN.BENKNG9.MUNG9.FNG9.BENEO.MXNEONARIMDTKRYSITCIIMUXHZNPHPR.MUHPR.FGTHXGNMKGMEDGM0N.FGM0N.BEG1H.FG1H.BEEXK.SGEXK.MUEXK.FEXK.BEEXASET82.SGET82.MUET82.FET82.DUET82.BEEPIXE031.FDRIODP81.SGDP81.FDP81.BEDMTKDFFNCTXRCBLIBP2M.FBP2M.BEBNTXN.MXBNTXAIKIAEZS.TOAEZSADAP8IN.MU8IN.F4KB.SG4KB.F4KB.BE47N.F473A.MU473A.F473A.BE2M6.MU2M6.F2M6.DE2M6.BE23I.MU23I.F23I.BE22UA.MU22UA.F22UA.DE22UA.BE1P5.SG1P5.F10VA.MU10VA.F10VA.BE0PT.FZEGA.SGZEGA.MUZEGA.FZEGA.BEZEG.SGZEG.MUZEG.FZEG.DEZEG.BEVKTXVCYTVARTXGTECHTE1.MUTE1.FTE1.BESXTCSWAVRPRXRPD.MURPD.FORMP.TAONCTOJU1.MUOJU1.FOJU1.BENVTA.MXNVTANVSN.MXNVSEFNVSNOVN.SWNOTA.MUNOTA.FNOTA.BENMTRMRK.PAMRK.MXMRKIV8.MUIV8.FIV8.BEIRWDINSPI76.FGXEA.FGXEA.BEGTU2.MUGTU2.FGLPGEVAXCTLTCLPTCERCC6K.FBPMCBNGO.MXBNGOBGNEBASIAZNN.MXAZNCFAZN.LAZNAVNSASLNANGNAMTIAGTC8HH.MU8HH.F8HH.BE7CB1.F7CB1.BE7A9.MU7A9.F7A9.BE6MK.MU6MK.F6MK.DE6MK.BE6160.HK49BA.SG36M.MU36M.F36M.BE2Y3.MU2Y3.BE2Q3.F2Q3.BE2L9.F2L9.BE2GT.MU2GT.F2GT.BE2DR.MU2DR.F2DR.BE1VT.MU1VT.F1VT.BE1KJ.MU1KJ.F1KJ.BE12V.F12V.BE0C8.MU0C8.F0C8.BEPFED.BAPFE.SGPFE.MXPFE.MUPFE.FPFE.DEPFE.BEPFEGENEDBTXBVSBLUEBLE.MUBLE.FAMGN.BAAMGNAMG.MUAMG.FAMG.DEAMG.BE- Published at
- by thestreet.com
mixedmixedINVESTIGATION ALERT: Halper Sadeh LLP Investigates MDCA, FFG, ALXN, NK, HLIX; Shareholders Are Encouraged To Contact The Firm
NEW YORK, Feb. 13, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:- Published at
- by prnewswire.com
positivepositiveSHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
/PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS...